USP21 promotes self-renewal and tumorigenicity of mesenchymal glioblastoma stem cells by deubiquitinating and stabilizing FOXD1

• Published in: Cell death & disease Vol. 13; no. 8; p. 712
• Main Authors: Zhang, Qixiang, Chen, Zhengxin, Tang, Qikai, Wang, Zhangjie, Lu, Jiacheng, You, Yongping, Wang, Huibo
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 16.08.2022; Springer Nature B.V; Nature Publishing Group
• Subjects: 13; 13/100; 13/89; 13/95; 14; 14/5; 38; 631/67/1922; 631/67/71; 64; 96; 96/109; Antibodies; Biochemistry; Biomedical and Life Sciences; Brain cancer; Brain Neoplasms - metabolism; Cell Biology; Cell Culture; Cell Line, Tumor; Cell self-renewal; Disulfiram; Enzymatic activity; Forkhead protein; Forkhead Transcription Factors - genetics; Forkhead Transcription Factors - metabolism; Glioblastoma; Glioblastoma - metabolism; Humans; Immunology; Life Sciences; Mesenchymal Stem Cells - metabolism; Mesenchyme; Neoplastic Stem Cells - metabolism; Patients; Peptidase; Proteasomes; Proteolysis; Stem cells; Therapeutic targets; Tumorigenicity; Ubiquitin; Ubiquitin Thiolesterase - genetics; Ubiquitin Thiolesterase - metabolism; Ubiquitination; Xenografts
• ISSN: 2041-4889; 2041-4889
• DOI: 10.1038/s41419-022-05163-3

Recent studies suggest that Forkhead box D1 (FOXD1) plays an indispensable role in maintaining the mesenchymal (MES) properties of glioblastoma (GBM) stem cells (GSCs). Thus, understanding the mechanisms that control FOXD1 protein expression is critical for guiding GBM treatment, particularly in patients with therapy-resistant MES subtypes. In this study, we identify the ubiquitin-specific peptidase 21 (USP21) as a critical FOXD1 deubiquitinase in MES GSCs. We find that USP21 directly interacts with and stabilizes FOXD1 by reverting its proteolytic ubiquitination. Silencing of USP21 enhances polyubiquitination of FOXD1, promotes its proteasomal degradation, and ultimately attenuates MES identity in GSCs, while these effects could be largely restored by reintroduction of FOXD1. Remarkably, we show that disulfiram, a repurposed drug that could block the enzymatic activities of USP21, suppresses GSC tumorigenicity in MES GSC-derived GBM xenograft model. Additionally, we demonstrate that USP21 is overexpressed and positively correlated with FOXD1 protein levels in GBM tissues, and its expression is inversely correlated with patient survival. Collectively, our work reveals that USP21 maintains MES identity by antagonizing FOXD1 ubiquitination and degradation, suggesting that USP21 is a potential therapeutic target for the MES subtype of GBM.